Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Paclical (micellar paclitaxel)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

HLB Bio Group, Vivesto, taiba

Drug class:

Bcl2 inhibitor, Tubulin inhibitor

Related drugs:

‹

BAY 59-8862 (0)

venetoclax (416)

paclitaxel (178)

albumin-bound paclitaxel (67)

paclitaxel oral (1)

oral paclitaxel/encequidar (1)

Bcl-2 Family Inhibitors (0)

paclitaxel polymeric micelle formulation (0)

paclitaxel liposomal (0)

liposomal paclitaxel (0)

paclitaxel nanoformulation (0)

paclitaxel-hyaluronic acid conjugate (0)

paclitaxel poliglumex (0)

bisphosphonate bound paclitaxel (0)

REGN5093-M114 (3)

vinblastine (3)

hIMB1636-MMAE (1)

BAY 59-8862 (0)

›

No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	carboplatin + micellar paclitaxel Sensitive: A1 - Approval carboplatin + micellar paclitaxel Sensitive : A1	carboplatin + micellar paclitaxel Sensitive: A1 - Approval carboplatin + micellar paclitaxel Sensitive : A1
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	carboplatin + micellar paclitaxel Sensitive: A1 - Approval carboplatin + micellar paclitaxel Sensitive : A1	carboplatin + micellar paclitaxel Sensitive: A1 - Approval carboplatin + micellar paclitaxel Sensitive : A1
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	carboplatin + micellar paclitaxel Sensitive: A1 - Approval carboplatin + micellar paclitaxel Sensitive : A1	carboplatin + micellar paclitaxel Sensitive: A1 - Approval carboplatin + micellar paclitaxel Sensitive : A1